| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15K | -89.1% |
| R&D Expense | $3.2M | +4.7% |
| SG&A Expense | $5.3M | +85.8% |
| Operating Income | -$8.4M | -47.4% |
| Pre-tax Income | -$12.3M | -30.3% |
| Net Income | -$12.3M | -30.3% |
| EPS (Basic) | -$0.31 | +82.7% |
| EPS (Diluted) | -$0.31 | +82.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $80K | -82.9% |
| Total Assets | $982K | +8.4% |
| Current Liabilities | $4.0M | +21.8% |
| Long-term Debt | $791K | — |
| Total Liabilities | $14.2M | +104.0% |
| Stockholders' Equity | -$13.8M | +36.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +3.7% |
| Capital Expenditures | $27K | -92.1% |
| Investing Cash Flow | $186K | +168.1% |
| Financing Cash Flow | $5.6M | -18.2% |
| Free Cash Flow | -$6.1M | +8.1% |